This activity is expired and is no longer available for CME credit.


Neovascular AMD: Retinal Fluid Management and Impact on Outcomes

Author(s)/Faculty: Sophie J. Bakri, MD; Roger A. Goldberg, MD, MBA; Yasha Modi, MD
Release Date: 4/13/2020Expiration Date: 4/12/2021
Credit Type: CME / ABO MOCNumber of Credits: 0
Content Type: LectureProvider:
The current goal for the management of patients with neovascular age-related macular degeneration (nAMD) is the elimination of retinal fluids as measured by optical coherence tomography. However, analysis of pinnacle clinical studies assessing anti-vascular endothelial growth factor (anti-VEGF) therapies for nAMD have not been able to confirm a constant correlation between retinal fluid reduction and visual outcomes. Furthermore, recent studies have provided strong evidence that different retinal fluids play a role in the progression and management of nAMD. In this educational activity, experts in the field will assess anatomical changes in the retina and their effect on the progression of nAMD, as well as evaluate the evidence regarding visual and anatomic outcomes achieved by anti-VEGF therapies in the management of patients with nAMD.